One year after Fetroja approval, Shionogi expands label to include difficult-to-treat pneumonia

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Sep 28, 2020 at 11:02 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via A year after snagging approval in complicated urinary tract infections, Shionogi’s antibiotic Fetroja has added another indication to its label: hospital-acquired and ventilator-associated bacterial pneumonia.

    article source